Medical Device | 30 March 2022
Medtronic commences PRAAN registry for stroke patients
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
As a partner with IRIA, the company had a significant booth presence on-ground during the conference.
Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
Vela Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
The TAT-5000 and the TAT-2000 thermometers for professional use by doctors and nurses and the TAT-2000C thermometer for consumer applications are based on a very innovative infrared technology
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
It signals Cordis' renewed investment in innovation
Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone
Subscribe To Our Newsletter & Stay Updated
